Normal view MARC view ISBD view

Spironolactone does not prevent restenosis after coronary stenting in humans.

Kursaklioglu, H

Spironolactone does not prevent restenosis after coronary stenting in humans. [electronic resource] - Annals of the Academy of Medicine, Singapore Nov 2004 - 769-74 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

ISSN: 0304-4602

Subjects--Topical Terms:
Adult
Aged
Coronary Restenosis--epidemiology
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Middle Aged
Spironolactone--therapeutic use
Treatment Failure

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)